$VTAK Catheter Precision, Inc. (NYSE: VTAK) Announ
Post# of 25327
https://www.accesswire.com/862316/catheter-pr...-nyse-vtak
FORT MILL, SC / ACCESSWIRE / May 13, 2024 / Catheter Precision, Inc. (the "Company" (NYSE American:VTAK), a US based innovative medical device company focused on electrophysiology products, announced additional product evaluations for its newest product, LockeT. As previously announced, the company has recently expanded their US sales and clinical team in preparation for the national product launch of LockeT.
"Since the introduction of the expanded commercial team, we have seen an increase in both scheduled and successful LockeT evaluations as well as purchase orders," said David Jenkins, CEO of Catheter Precision.
"We have eight new representatives that have brought about several new hospitals scheduled to begin LockeT evaluations in the coming weeks," said Marie-Claude Jaques, newly appointed Chief Commercial Officer of Catheter Precision.